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Cancer and How the Community Responses to Nutrition Factors in 
Developing Country Nepal
Bohara, Amrit B. 
Community Health and Environmental Society, Kathmandu, Nepal
Objective: The prevalence rate of cancer in Nepal is high. Due to pov-
erty and illiteracy, ost of the patient come to the hospital in later stage. 
smoking and indoor pollution is major problem in urban and rural 
community of Nepal. This study was to ﬁnd out the epidemiology and 
prevalence of lung cancer in community. Methods:A case-control study 
involving interviews and clinical reports with 764 patients with lung 
cancer and 795 population-based controls was conducted in different 
part of Nepal, where mortality rates are high among men and women
Results: Cigarette smoking was found to be the principal cause of 
lung cancer in this population, accounting for 55% of the lung cancers 
in males and 37% in females. The attributable risk percentage among 
females is high compared to elsewhere in Nepal, largely because of a 
higher prevalence of smoking with local made alcohol among women 
and poor nutrition diet. After adjustment for smoking, there were 
also signiﬁcant increases in lung-cancer risk associated with several 
measures of exposure to air pollutants. Risks were twice as high among 
those who reported smoky outdoor environments, and increased in 
proportion to years of sleeping on beds heated by coal-burning stoves 
(chulo), and to an overall index of indoor air pollution. Threefold 
increase in lung cancer risk was found among men industrial occupa-
tion. The associations with both smoking and indoor air-pollution were 
stronger for squamous cell and small cell carcinomas than for adeno-
carcinoma of the lung. The patient intakes mostly smoked food and 
having poor vegetables and fruits regularly. 
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Background: Lung cancer is a major cause of cancer-related death in 
developed countries and the incidence of this type of cancer is increas-
ing in developing countries. In Thailand, cancer incidences greatly 
differ from region to region, and in the Northern region lung cancer 
is the most frequent. Although the geographical variability in cancer 
patterns reﬂects exposure of the population to different environmental 
risk factors unique to the different regions, a possible role of genetic 
polymorphism as an individual risk modiﬁer for lung cancer has been 
addressed. In this study the polymorphisms of the well-investigated ge-
netic susceptibility genes, including cytochrome P450 (CYP1A1MspI, 
CYP2E1DraI, CYP2E1PstI), glutathione S-transferase (GSTM1, 
GSTT1) myeloperoxidase (MPO) and matrix metalloproteinase-1 
(MMP-1) in relations to lung cancer in the Northern Thai population 
was investigated. 
Methods: In 62 cases (39 males, 23 females) and 75 controls (31 
males, 44 females) polymorphisms were examined by multiplex-
PCR for GSTM1 and GSTT1, and by PCR-RFLP for CYP1A1MspI, 
CYP2E1DraI, CYP2E1PstI, MPO(-463G/A) and MMP-1(-1607 
1G/2G). Mean (SD) age was 59.2 (9.91) and 56.4 (13.7) years in the 
cases and controls, respectively.
Results: The observed allele frequencies of all of the genes studied 
were within the range previously described for the Asian population. 
The overall analysis showed that polymorphisms of all the genes 
studied were not signiﬁcantly associated with an increase risk of lung 
cancer. The risk of lung cancer was further examined by stratiﬁcation 
with smoking status and the odds ratios were calculated by logistic re-
gression with wild-type genotype as the reference group for non-smok-
ers and adjusted for age and gender. Among non-smokers, GSTM1 
null genotype signiﬁcantly increased the risk of lung cancer among 
non-smokers (OR=15.6, 95%-CI: 1.61-142.8). None of the other poly-
morphisms showed any signiﬁcant impact on lung cancer risk. Among 
smokers, odds ratio in smokers with GSTM1 null genotype (OR=52.5, 
95%-CI: 5.13-537.8) was higher than those carrying GSTM1 positive 
genotype (OR=41.4, 95%-CI: 4.59-376.1). Although variant alleles of 
MPO and MMP-1 did not show any impact on lung cancer risk in non-
smokers, it was found that odds ratio in smokers with MPO homozy-
gous variants (A/A) or heterozygous variants (A/G) (OR=12.46, 95%-
CI: 3.02-51.32) and smokers with MMP homozygous variants (2G/2G) 
(OR=7.49, 95%-CI: 2.20-25.42) was signiﬁcantly elevated compared 
to smokers who carried wild-type genotype of both genes, respectively 
(OR=6.60, 95%-CI: 2.41-18.07 and OR=2.98, 95%-CI: 0.60-14.67). 
This induction of OR may indicate a joint effect of the interaction be-
tween tobacco smoking and the MPO and MMP-1 polymorphism.
Conclusion: Our preliminary results indicate that polymorphisms of 
the GSTM1, MPO or MMP-1 have a modifying effect on smoking and 
lung cancer risk in the Northern Thai population; however, a larger 
sample population is necessary to conﬁrm our ﬁndings. 
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A retrospective study of patients with advanced non-small cell lung 
cancer and malignant pleural effusion.
Karrim, Juliana; Hwang, Jimmy; Jahan, Thierry; Jablons, David; 
Dubey, Sarita 
University of California, San Francisco, CA, USA
Background: Prior studies of patients with non-small cell lung cancer 
(NSCLC) have shown that those diagnosed with stage IIIB with pleural 
effusion (PE) have a worse prognosis than those without PE. We plan 
to further analyze the characteristics of 4 subgroups of patients with 
advanced stage non-small cell lung cancer.
Method: Data was collected retrospectively from medical records of 
patients identiﬁed through the cancer registry. All patients identiﬁed 
had a diagnosis of NSCLC stage IIIB and IV, and were seen at Univer-
sity of California, San Francisco, between years 2000-2004. Statistical 
studies were done to ﬁnd associations between baseline characteristics 
and survival. Survival analysis was calculated by Kaplan Meier meth-
od. Cox proportional hazards regression model was used to conﬁrm the 
signiﬁcance of each prognostic factor selected by univariate analysis. 
The Institutional Review Board approved this study. 
